AnyGen Co Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares AnyGen Co Ltd with three other
pharmaceutical manufacturers in Asia:
Krebs Biochemicals & Industries Limited
of INDIA
(2019
sales of 477.58 million Indian Rupees [US$6.55 million]
),
Deccan Health Care Ltd
of INDIA
(442.48 million Indian Rupees [US$6.07 million]
of which 100%
was Fast moving consumer health products), and
Phong Phu Pharmaceutical JSC
which is
based in VIETNAM
(151.11 billion Vietnamese Dong [US$6.54 million]
).
Sales Analysis.
AnyGen Co Ltd reported sales of 6.28 billion Korean Won (US$5.69 million)
for the
year ending
December of 2019.
This
represents
an
increase of 52.6%
versus 2018, when the company's sales were 4.11 billion Korean Won .